omniture
Clover Biopharmaceuticals

Latest News

Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort

-- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralization titers to approximately 6...

2024-04-08 17:19 1394

Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)

--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a s...

2023-12-29 07:30 2059

Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate

--First Chinese RSV PreF Vaccine Candidate to Enter Clinical Trial Stage-- SHANGHAI, Dec. 13, 2023 ...

2023-12-13 07:42 1438

Clover Completes BLA Submission for Seasonal Influenza Vaccine in Brazil

-- Clover's seasonal influenza vaccine BLA submission has been completed in Brazil, boosting Clover...

2023-11-07 08:00 1373